Latest Regulatory Approval News

Wingara Limited has entered an exclusive agreement with Terra Firma Limited to explore and acquire meat industry businesses, securing $750,000 in initial funding. Trading on the ASX is suspended pending re-compliance and relisting.

Sayona Mining's March 2025 quarterly report reveals operational setbacks at North American Lithium due to adverse weather and maintenance, yet the company maintains full-year guidance and progresses a transformative merger with Piedmont Lithium.

Dart Mining has entered a $3.4 million option agreement with Infinity Lithium to divest its non-core Victorian exploration assets, enabling Dart to sharpen its focus on Queensland projects while Infinity expands in Victoria.

Prospect Resources has declared a maiden JORC-compliant copper resource of 107.2 million tonnes at 0.5% copper at its Mumbezhi Project in Zambia, alongside securing a strategic A$15.2 million investment from First Quantum Minerals. This milestone advances the project towards development with Phase 2 drilling planned for Q2 2025.

TruScreen has launched a landmark five-year cervical cancer screening program in Ho Chi Minh City, targeting 260,000 women with its AI-driven, non-invasive technology to boost screening rates and support Vietnam’s national health goals.

De Grey Mining Ltd proposes a scheme of arrangement for acquisition by Northern Star Resources Ltd, offering a 37.1% premium and resulting in a 20% stake for De Grey shareholders in the merged group. The scheme booklet, including an Independent Expert's Report by KPMG, concludes the scheme is fair and reasonable and in the best interests of De Grey shareholders, subject to no superior proposal.

Minerals 260 Limited has launched a $200-$220 million public offer to fund the acquisition of the Bullabulling Gold Project in Western Australia, featuring a 2.3 million ounce JORC-compliant resource. The company seeks ASX re-admission following a significant change in scale of activities.

Nyrada Inc. posted a significant $2.46 million loss for H1 FY25, driven by increased R&D spend, while advancing its lead drug NYR-BI03 into first-in-human trials following regulatory approval.

Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.

Ausmon Resources has completed critical field reconnaissance across three South Australian tenements, setting the stage for a targeted rare earth elements drilling program pending regulatory approval.

Propel Funeral Partners has agreed to acquire two historic New Zealand funeral service providers, marking a strategic expansion into new regional markets with an acquisition valued at up to A$7.3 million.

Adriatic Metals has announced a two-tranche institutional placement to raise A$80 million, aiming to fast-track the expansion of its Vares Processing Plant and strengthen its balance sheet ahead of commercial production.